BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27903975)

  • 1. Cortactin promotes colorectal cancer cell proliferation by activating the EGFR-MAPK pathway.
    Zhang X; Liu K; Zhang T; Wang Z; Qin X; Jing X; Wu H; Ji X; He Y; Zhao R
    Oncotarget; 2017 Jan; 8(1):1541-1554. PubMed ID: 27903975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asporin enhances colorectal cancer metastasis through activating the EGFR/src/cortactin signaling pathway.
    Wu H; Jing X; Cheng X; He Y; Hu L; Wu H; Ye F; Zhao R
    Oncotarget; 2016 Nov; 7(45):73402-73413. PubMed ID: 27705916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pTyr421 cortactin is overexpressed in colon cancer and is dephosphorylated by curcumin: involvement of non-receptor type 1 protein tyrosine phosphatase (PTPN1).
    Radhakrishnan VM; Kojs P; Young G; Ramalingam R; Jagadish B; Mash EA; Martinez JD; Ghishan FK; Kiela PR
    PLoS One; 2014; 9(1):e85796. PubMed ID: 24465712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfiredoxin Promotes Colorectal Cancer Cell Invasion and Metastasis through a Novel Mechanism of Enhancing EGFR Signaling.
    Jiang H; Wu L; Chen J; Mishra M; Chawsheen HA; Zhu H; Wei Q
    Mol Cancer Res; 2015 Dec; 13(12):1554-66. PubMed ID: 26290602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor.
    Timpson P; Lynch DK; Schramek D; Walker F; Daly RJ
    Cancer Res; 2005 Apr; 65(8):3273-80. PubMed ID: 15833860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of cortactin in head and neck squamous cell carcinomas can be uncoupled from augmented EGF receptor expression.
    Fantozzi I; Grall D; Cagnol S; Stanchi F; Sudaka A; Brunstein MC; Bozec A; Fischel JL; Milano G; Van Obberghen-Schilling E
    Acta Oncol; 2008; 47(8):1502-12. PubMed ID: 18607838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib.
    Timpson P; Wilson AS; Lehrbach GM; Sutherland RL; Musgrove EA; Daly RJ
    Cancer Res; 2007 Oct; 67(19):9304-14. PubMed ID: 17909038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortactin promotes colon cancer progression by regulating ERK pathway.
    Ni QF; Yu JW; Qian F; Sun NZ; Xiao JJ; Zhu JW
    Int J Oncol; 2015 Sep; 47(3):1034-42. PubMed ID: 26151562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor-C upregulates cortactin and promotes metastasis of esophageal squamous cell carcinoma.
    Su CM; Su YH; Chiu CF; Chang YW; Hong CC; Yu YH; Ho YS; Wu CH; Yen CS; Su JL
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S767-75. PubMed ID: 25212831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortactin promotes cell migration and invasion through upregulation of the dedicator of cytokinesis 1 expression in human colorectal cancer.
    Jing X; Wu H; Ji X; Wu H; Shi M; Zhao R
    Oncol Rep; 2016 Oct; 36(4):1946-1952. PubMed ID: 27633051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective β2-AR Blockage Suppresses Colorectal Cancer Growth Through Regulation of EGFR-Akt/ERK1/2 Signaling, G1-Phase Arrest, and Apoptosis.
    Chin CC; Li JM; Lee KF; Huang YC; Wang KC; Lai HC; Cheng CC; Kuo YH; Shi CS
    J Cell Physiol; 2016 Feb; 231(2):459-72. PubMed ID: 26189563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortactin expression: Association with disease progression and survival in oral squamous cell carcinoma.
    Horn D; Gross M; Dyckhoff G; Fuchs J; Grabe N; Weichert W; Herpel E; Herold-Mende C; Lichter P; Hoffmann J; Hess J; Freier K
    Head Neck; 2018 Dec; 40(12):2685-2694. PubMed ID: 30456890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pinin facilitated proliferation and metastasis of colorectal cancer through activating EGFR/ERK signaling pathway.
    Wei Z; Ma W; Qi X; Zhu X; Wang Y; Xu Z; Luo J; Wang D; Guo W; Li X; Xin S; Yu J; Li G
    Oncotarget; 2016 May; 7(20):29429-39. PubMed ID: 27107420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma.
    Du XL; Yang H; Liu SG; Luo ML; Hao JJ; Zhang Y; Lin DC; Xu X; Cai Y; Zhan QM; Wang MR
    Oncogene; 2009 Oct; 28(42):3714-22. PubMed ID: 19684620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-542-3p inhibits the growth and invasion of colorectal cancer cells through targeted regulation of cortactin.
    Long HC; Gao X; Lei CJ; Zhu B; Li L; Zeng C; Huang JB; Feng JR
    Int J Mol Med; 2016 Apr; 37(4):1112-8. PubMed ID: 26952924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of USP4 to cortactin enhances cell migration in HCT116 human colon cancer cells.
    Yun SI; Kwak C; Lee SY; Shin S; Oh C; Kim JS; Rhee HW; Kim KK
    FASEB J; 2023 May; 37(5):e22900. PubMed ID: 37039823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR4 promotes metastasis via ERK/NF-κB/MMP13 pathway and acts downstream of TNF-α in colorectal cancer.
    Ou B; Zhao J; Guan S; Feng H; Wangpu X; Zhu C; Zong Y; Ma J; Sun J; Shen X; Zheng M; Lu A
    Oncotarget; 2016 Jul; 7(30):47637-47649. PubMed ID: 27356745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.
    Rothschild BL; Shim AH; Ammer AG; Kelley LC; Irby KB; Head JA; Chen L; Varella-Garcia M; Sacks PG; Frederick B; Raben D; Weed SA
    Cancer Res; 2006 Aug; 66(16):8017-25. PubMed ID: 16912177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CBLC inhibits the proliferation and metastasis of breast cancer cells via ubiquitination and degradation of CTTN.
    Li W; Lei T; Song X; Deng C; Lu J; Zhang W; Kuang Z; He Y; Zhou Q; Luo Z; Mo F; Yang H; Hang J; Xiao B; Li L
    J Recept Signal Transduct Res; 2022 Dec; 42(6):588-598. PubMed ID: 36043996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-invasive Effect of Proto-oncogene PBF Is Modulated by an Interaction with Cortactin.
    Watkins RJ; Imruetaicharoenchoke W; Read ML; Sharma N; Poole VL; Gentilin E; Bansal S; Bosseboeuf E; Fletcher R; Nieto HR; Mallick U; Hackshaw A; Mehanna H; Boelaert K; Smith VE; McCabe CJ
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4551-4563. PubMed ID: 27603901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.